promegestone has been researched along with Uterine Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (60.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulun, SE; Coon, JS; Kujawa, SA; Liu, S; Okeigwe, I; Yin, P | 1 |
| Barker, NM; Caplan, AI; Carrino, DA; Hurd, WW; Liu, JH; Mesiano, S; Tan, H | 1 |
| Britten, J; Catherino, WH; Cox, J; Malik, M; Patel, A | 1 |
| Berry, E; Bulun, S; Chakravarti, D; Clardy, J; Hardt, J; Hoekstra, AV; Kim, JJ; Lu, Z; Marsh, E; Sefton, EC; Yin, P | 1 |
| Karteris, E; Mparmpakas, D; Rand-Weaver, M; Thomas, P; Zachariades, E | 1 |
| Bulun, SE; Cheng, YH; Innes, J; Ishikawa, H; Kim, JJ; Lin, Z; Marsh, EE; Reierstad, S; Thung, S; Utsunomiya, H; Xu, E; Xue, Q; Yin, P | 1 |
| Andersen, RN; Costlow, ME; ElDeib, MM | 1 |
| Andersen, RN; ElDieb, MR | 1 |
| Freeman, L; Jiang, NS; Thibodeau, SN | 1 |
| Ferenczy, A; Shyamala, G | 1 |
| Büchi, KA; Genton, CY | 1 |
| Arnold, SF; Klotz, DM; McLachlan, JA | 1 |
| Al-Azzawi, F; Thompson, J; Wahab, M | 1 |
| Matsumoto, K; Shimizu, I; Tanizawa, O; Terakawa, N | 1 |
| Cavaillès, V; Defrenne, A; Garcia, M; Rochefort, H; Touitou, I | 1 |
| Bahary, CM; Beery, R; Geier, A; Gorodeski, IG; Lunenfeld, B; Neri, A | 1 |
| Tanizawa, O; Terakawa, N | 1 |
| Clarke, CL; Mortel, R; Satyaswaroop, PG; Zaino, RJ | 1 |
| Aono, T; Hayashida, M; Ikegami, H; Matsumoto, K; Nishida, M; Shimizu, I; Tanizawa, O; Terakawa, N; Wakimoto, H | 1 |
| Clarke, CL; Satyaswaroop, PG | 1 |
1 review(s) available for promegestone and Uterine Neoplasms
| Article | Year |
|---|---|
Sex steroid receptors in normal and malignant endometrium.
Topics: Affinity Labels; Animals; Cytosol; Endometrium; Epithelium; Estradiol; Estradiol Dehydrogenases; Female; Histocytochemistry; Humans; Immunologic Techniques; Kinetics; Molecular Weight; Neoplasm Transplantation; Photochemistry; Progesterone; Promegestone; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1986 |
1 trial(s) available for promegestone and Uterine Neoplasms
| Article | Year |
|---|---|
The effect of submucous fibroids on the dose-dependent modulation of uterine bleeding by trimegestone in postmenopausal women treated with hormone replacement therapy.
Topics: Dose-Response Relationship, Drug; Endometrium; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Middle Aged; Postmenopause; Progesterone Congeners; Promegestone; Uterine Hemorrhage; Uterine Neoplasms | 2000 |
18 other study(ies) available for promegestone and Uterine Neoplasms
| Article | Year |
|---|---|
Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
Topics: Adult; Cell Proliferation; DNA Methylation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Mediator Complex; Middle Aged; Progesterone; Promegestone; RANK Ligand; Receptors, Progesterone; Stem Cells; Transcription Initiation Site; Transcriptional Activation; Uterine Neoplasms | 2019 |
Proteoglycans in Leiomyoma and Normal Myometrium: Abundance, Steroid Hormone Control, and Implications for Pathophysiology.
Topics: Adult; Cell Line, Transformed; Cell Line, Tumor; Decorin; Estradiol; Female; Humans; Leiomyoma; Middle Aged; Myometrium; Progesterone; Promegestone; Proteoglycans; Uterine Neoplasms | 2016 |
Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.
Topics: Cell Line, Transformed; Dose-Response Relationship, Drug; Extracellular Matrix; Female; Hormone Antagonists; Humans; Leiomyoma; Mifepristone; Promegestone; Tumor Cells, Cultured; Uterine Neoplasms | 2016 |
Progestins activate the AKT pathway in leiomyoma cells and promote survival.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Female; Fluorescent Antibody Technique; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Leiomyoma; Mifepristone; Oncogene Protein v-akt; Phosphorylation; Progestins; Promegestone; Signal Transduction; Uterine Neoplasms | 2009 |
Crucial cross-talk of interleukin-1β and progesterone in human choriocarcinoma.
Topics: Butadienes; Cell Death; Cell Line, Tumor; Choriocarcinoma; Female; Humans; Interleukin-1beta; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Pregnancy; Progesterone; Promegestone; Protein Kinase Inhibitors; Receptors, Progesterone; Signal Transduction; Time Factors; Tumor Microenvironment; Uterine Neoplasms | 2012 |
Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells.
Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Female; Gene Expression Regulation; Genes, bcl-2; Humans; Leiomyoma; Luciferases; Progesterone; Promegestone; Promoter Regions, Genetic; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Uterine Neoplasms | 2007 |
Ligand-induced change in sedimentation behavior of human progestin receptors.
Topics: Centrifugation, Density Gradient; Chemical Phenomena; Chemistry; Cytosol; Durapatite; Endometrium; Female; Humans; Hydroxyapatites; Leiomyoma; Ligands; Myometrium; Promegestone; Protamines; Receptors, Progesterone; Uterine Neoplasms | 1983 |
The effect of leupeptin on progestin receptors of human uterine tissues.
Topics: Centrifugation, Density Gradient; Drug Stability; Endometrium; Female; Humans; Leiomyoma; Leupeptins; Myometrium; Oligopeptides; Promegestone; Receptors, Progesterone; Specimen Handling; Uterine Neoplasms; Uterus | 1982 |
Simultaneous measurement of estrogen and progesterone receptors in tumor cytosols with use of 125I-labeled estradiol and of 3H-R5020.
Topics: Breast Neoplasms; Cytosol; Estradiol; Female; Humans; Iodine Radioisotopes; Isotope Labeling; Kinetics; Norpregnadienes; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Tritium; Uterine Neoplasms | 1981 |
The effect of sodium molybdate on the cytoplasmic estrogen and progesterone receptors in human endometrial tissues.
Topics: Adenocarcinoma; Adult; Aged; Centrifugation, Density Gradient; Culture Techniques; Endometrium; Estradiol; Female; Humans; Middle Aged; Molybdenum; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1981 |
Are the histological and ultrastructural features of endometrial carcinomas reliable indicators of their steroid receptor content?
Topics: Aged; Estradiol; Female; Humans; Menopause; Middle Aged; Promegestone; Receptors, Steroid; Uterine Neoplasms | 1982 |
Inhibition of 17 beta-estradiol and progesterone activity in human breast and endometrial cancer cells by carbamate insecticides.
Topics: Binding, Competitive; Breast Neoplasms; Carbamates; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Insecticides; Luciferases; Progesterone; Progesterone Congeners; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1997 |
RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
Topics: Binding, Competitive; Cell Division; Cellulose; Cytoplasm; DNA; Estrenes; Female; Glycogen; Humans; Mifepristone; Periodic Acid-Schiff Reaction; Progestins; Promegestone; Receptors, Progesterone; Staining and Labeling; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells.
Topics: Animals; Blotting, Northern; Breast Neoplasms; Cathepsin D; Cell Line; Epidermal Growth Factor; Estradiol; Female; Gene Expression Regulation; Gonadal Steroid Hormones; Humans; In Vitro Techniques; Promegestone; Rats; RNA, Messenger; Transfection; Uterine Neoplasms | 1989 |
Characterization of the nuclear progesterone receptor in human uterine leiomyoma.
Topics: Cell Nucleus; Cytosol; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Kinetics; Leiomyoma; Middle Aged; Progesterone; Promegestone; Receptors, Progesterone; Uterine Neoplasms | 1986 |
[Growth inhibition by progestins in human endometrial cancer cells with progesterone receptors].
Topics: Cell Division; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Neoplasms, Hormone-Dependent; Progesterone Congeners; Promegestone; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
Topics: Cell Division; Cell Line; Cell Survival; Estradiol; Female; Humans; Norpregnadienes; Progesterone; Promegestone; Receptors, Progesterone; Uterine Neoplasms | 1987 |
Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma.
Topics: Affinity Labels; Animals; Estradiol; Female; Humans; Mice; Mice, Inbred BALB C; Molecular Weight; Promegestone; Receptors, Progesterone; Tamoxifen; Tritium; Uterine Neoplasms | 1985 |